Related Experiment Video

Updated: May 7, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

289

Management and Treatment of Primary Membranous Nephropathy With a Positive PLA2R Marker

Rajesh Metuku1, Austin B Wynn1, Raul Santos2

  • 1Research Department, Alabama College of Osteopathic Medicine, Dothan, USA.

Cureus
|January 6, 2025
PubMed

Insights

Membranous nephropathy, an autoimmune kidney disease, involves antibodies attacking the PLA2R receptor. This case highlights the complex interplay of PLA2R antibodies and HIV in kidney failure.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Membranous nephropathy is an autoimmune kidney disease targeting the Phospholipase A2 Receptor (PLA2R).
  • PLA2R-associated membranous nephropathy often leads to nephrotic syndrome and end-stage renal disease.
  • Co-occurrence of HIV complicates the understanding and management of kidney pathologies.

Observation:

  • A patient with a history of HIV presented with nephrotic syndrome and significant proteinuria.
  • Kidney biopsy revealed sclerotic and fibrotic damage with positive anti-PLA2R antibodies.
  • Despite treatment with tacrolimus and cyclophosphamide, the patient progressed to requiring dialysis.

Findings:

  • The case presents a unique challenge due to the concurrent presence of anti-PLA2R antibodies and HIV infection.
  • The combined pathologies likely contributed to the patient's rapid decline in kidney function.
  • Treatment efficacy was limited, underscoring the complexity of managing co-existing conditions.

Implications:

  • This case underscores the need for further research into the synergistic effects of HIV and PLA2R autoimmunity on kidney health.
  • Understanding these complex interactions is crucial for developing improved therapeutic strategies.
  • Further investigation may lead to better treatment options and improved prognoses for patients with similar conditions.
Keywords:
auto immuneend stage renal disease (esrd)idiopathic nephrotic syndromeplar2primary membranous nephropathy

More Related Videos

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy09:46

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Published on: February 26, 2021

3.1K
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

11.4K

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
89
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
46